(lp0
S'Albireo Pharma Inc. ALBO  Wall Street Journal - Feb 1, 2001 News Albireo Pharma Inc.ALBO. Significant News Only. 03/07/17; Press Release. Albireo to Host Conference Call and Webcast on March 14 at 8:30 a.m.'
p1
aS'BRIEF-Albireo Pharma Inc says filed for mixed shelf offering of up to $100 mln Reuters - Dec 22, 2016 BERLIN, Feb 12 Greece and its lenders should quickly approve a review of reforms the indebted country must take in return for unlocking new loans, a senior European Union official said on Sunday, warning of financial instability in the euro zone if the ...'
p2
aS"Albireo Completes Transaction with Biodel to Create Publicly Traded Company ... GlobeNewswire  - Nov 3, 2016 BOSTON, Nov. 03, 2016  -- Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators through its operating subsidiary, today announced the completion of the share exchange&nbsp;...Nine stories you may have missed Thursday from the world of business - The Boston GlobeBoston's newest public company, Albireo, aims to treat kids' liver diseases - Boston Business Journal"
p3
aS'Albireo Pharma Inc. MarketWatch - Nov 9, 2016 Check out the returns on our 8 Lazy Portfolios that are made up of low-cost buy-and-hold index funds.  How to create your own Lazy Portfolio.'
p4
aS'ALBIREO PHARMA, INC.  Files An 8-K Departure of Directors or ... Market Exclusive - Jan 27, 2017 On January 23, 2017, the Board of Directors  of Albireo Pharma, Inc. , acting upon the recommendation of the Compensation Committee of the Board , approved an increase in the annual base&nbsp;...'
p5
aS"Noteworthy Stock of Tuesday: Albireo Pharma, Inc.'s  stock price settles ... WsNews 4investors - 22 hours ago Albireo Pharma, Inc.  stock price tumbled -6.71% to finalize at $23.50 throughout previous buying and selling session.Albireo Reports 2016 Financial Results - Yahoo Finance"
p6
aS'Boston biotech Albireo goes public in unusual fashion The Boston Globe - Nov 3, 2016 Boston biotech Albireo Pharma Inc. went public Thursday through a reverse merger in which it acquired the stock listing of a Connecticut company, in a deal that will leave Albireo with about $30 million to develop a treatment for a pediatric liver disease.'
p7
aS'Albireo Pharma  Partner Submits NDA for Elobixibat in Japan StreetInsider.com - Feb 1, 2017 Albireo Pharma, Inc.  announced that EA Pharma Co., Ltd. has submitted a New Drug Application  to the Japanese Pharmaceuticals and Medical Devices Agency  for elobixibat for the treatment of chronic constipation in Japan.'
p8
aS'Biodel completes round trip related to Albireo merger; shares down 14% Seeking Alpha - May 26, 2016 Tuesday evening, the company announced that it would combine with privately held Albireo. The new company will do business as Albireo Pharma and trade under the symbol &quot;ALBO.&quot; A syndicate of institutional investors, including AstraZeneca &nbsp;...'
p9
aS"Albireo Pharma Doubles In A Week Benzinga - Nov 21, 2016 Albireo Pharma, Inc.  shares are trading higher by $5.25  at $31.25 in Monday's session."
p10
a.